Orthobiologics Market – Size, Share, Growth, Trends | MarketsandMarkets™
According
to the new market research report ” Orthobiologics Market by Product
(Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC,
Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft
Tissue), End User (Hospitals, ASCs, Academia) – Global Forecast to 2022″,
published by MarketsandMarkets™, The global orthobiologics market is expected
to...
Orthobiologics Market by Product, Application and End-user
The global orthobiologics market is projected to reach USD 6.06 Billion by 2022 from USD 4.66 Billion in 2017, at a CAGR of 5.4% during the forecast period. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high...
Medtronic plc (Ireland) and DePuy Synthes, Inc. (US) are the leaders in the orthobiologics market
Medtronic plc (Ireland) is a leader in the orthobiologics market with its synthetic bone graft substitutes and bone morphogenetic proteins products. Its among the only companies providing BMP. The company has a wide geographic presence across 155 countries.
Medtronic primarily focuses on organic and inorganic business strategies such as product approvals, product launches, and acquisitions. In 2015,...